Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA gyrase subunit A (GyrA) is one of the two essential protein components of bacterial DNA gyrase, a type II topoisomerase unique to prokaryotes. DNA gyrase introduces negative supercoils into closed circular double-stranded DNA in an ATP-dependent manner, which is critical for processes such as replication, transcription, and recombination. The enzyme is a heterotetramer composed of two GyrA and two GyrB subunits (A₂B₂ complex). GyrA is the target of fluoroquinolone antibiotics.
Inhibition of DNA religation after cleavage by binding at or near the active site
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA gyrase subunit A (None).